Mannitol

🧮 Dose calculator

Raised intracranial pressure and cerebral oedema · Regimen source: FDA Osmitrol · 2.2

• • Preferably a central vein. Assess renal, cardiac and pulmonary status and correct electrolytes first; monitor osmolality. Not with blood products in the same set. FDA Osmitrol · 2.1FDA Osmitrol · 2.2

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Osmitrol · 8.1

  “Risk Summary The available case report data with mannitol over decades of use have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Osmitrol · 8.2

  “Risk Summary There are no data on the presence of mannitol in either human or animal milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Osmitrol · 8.4

  “OSMITROL is approved for use in the pediatric population for the reduction of intracranial and intraocular pressure.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Osmitrol · 8.5

  “Evaluate the renal, cardiac and pulmonary status of the patient and correct fluid and electrolyte imbalances prior to administration of OSMITROL [see Warnings and Precautions (5.2 , 5.3 , 5.4 , 5.5 )].”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.